Ingen internetforbindelse — viser den gemte version af siden.

enGene Therapeuti…

CACAD
← Til screeneren

enGene Therapeutics Inc. (US:ENGN) — Biotechnology: Biological Products (No Diagnostic Substances). Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
engene.com
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Hovedkontor
SAINT-LAURENT, Canada
Administrerende direktør
Mr. Ronald H. W. Cooper
Ansatte
81
Udestående aktier
67.02 mio. pr. 2026-09-02
Free float
32.75 mio.
Markedsværdi
132.02 mio. USD
Insidere
0.11%
Institutionelle investorer
84.11%
Branche (SIC)
Biological Products, (No Diagnostic Substances)
Beskrivelse

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksENGNUSD1.8 -3.74%almindelige aktier

Kurs over 3 måneder

US:ENGN · USD
stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Ingen udbyttebetalinger fundet (tjekket 07.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
FCPM III Services B.V.14.37%9.63 mio.2026-06-30
BML Capital Management,…9.95%6.67 mio.2026-06-30
Siren, L.L.C.9.34%6.26 mio.2026-06-30
Perceptive Advisors Llc7.2%4.82 mio.2026-06-30
Ameriprise Financial, In…3.99%2.68 mio.2026-06-30
Nextech Invest, Ltd.3.47%2.32 mio.2026-06-30
Adar1 Capital Management…3.14%2.1 mio.2026-06-30
Vestal Point Capital, LP2.49%1.67 mio.2026-06-30
Acorn Capital Advisors,…1.9%1.27 mio.2026-06-30
Peapod Lane Capital LLC1.64%1.1 mio.2026-06-30
Franklin Strategic Serie…0.73%486 5792026-04-30
Fidelity Concord Street…0.05%34 9822026-07-31
ETFis Series Trust I-Vir…0.05%32 6252026-04-30
TIFF INVESTMENT PROGRAM-…0.02%10 6392026-06-30
JNL Series Trust-JNL/DFA…0.01%9 9742026-06-30
Exchange Place Advisors…0.01%7 6492026-06-30
GROSSMAN WILLIAM (Office…≈0.01%5 1022026-09-22
Advanced Series Trust-AS…0%1 3762026-06-30
FORBION GROWTH OPPORTUNI…——2024-10-30